Management  :  Alliances & Partnerships  :  Investors  :   Board of Directors  :   Advisors

Mike worked for Amersham plc (now GE Healthcare) between 1976 and 2006. He played a key role in the development of Amersham in a number of senior management posts and became Executive Vice President Bioscience Operations. Since 2006, Mike has acted as a consultant to GE Healthcare. Mike has extensive experience negotiating at a senior level in the regulatory fields of nuclear operations and pharmaceutical manufacturing in Europe and the USA . He has wide experience of GMP pharmaceutic manufacturing. He has also acquired qualifications in finance and accounting and an MBA.

George lectured in mechanical engineering before joining the UK Atomic Energy Authority, where he carried out research into heat transfer and fluid flow problems relevant to the cooling of nuclear reactors. For the past decade he has worked with Brian Bellhouse, developing and refining the needle-free injection devices which form the core technology of the Company’s project.

Heiko came to the UK in 2006 to set up a research laboratory for protein particle formulation and bioanalytics at the University of Oxford. He is a registered pharmacist specializing in drug delivery and pharmaceutical technology. He holds a PhD in drug delivery and particle formulation of therapeutic peptides and proteins from the University of Erlangen, and is a noted spray-drying and spray-freeze-drying specialist.

Chief Technical Officer: to be appointed

Finance Manager: to be appointed

Company Administrator: to be appointed